Skip to main content

Abolis Biotechnologies

Évry, France

Abolis is delivering high-impact innovations in biotechnologies.We provide tailor-made industrial solutions based on micro-organisms.

$38.8M raised
Sep 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Abolis Biotechnologies

How much funding has Abolis Biotechnologies raised?
Abolis Biotechnologies has raised $38.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Who are Abolis Biotechnologies's investors?
Abolis Biotechnologies's investors include Clay Capital, Evonik Venture Capital, Liberset, DeepTech & Climate Fonds, ICOS Capital Management.
Where is Abolis Biotechnologies headquartered?
Abolis Biotechnologies is headquartered in Évry, France.
What does Abolis Biotechnologies do?
Abolis is delivering high-impact innovations in biotechnologies.We provide tailor-made industrial solutions based on micro-organisms.
What stage is Abolis Biotechnologies at?
Abolis Biotechnologies is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Abolis Biotechnologies — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/abolis-biotechnologies. Accessed July 2, 2026.
APA
VCBacked. (2024). Abolis Biotechnologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/abolis-biotechnologies
Wikipedia (cite web)
{{cite web |title=Abolis Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/abolis-biotechnologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .